Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults
It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting...
Saved in:
Published in | mBio Vol. 11; no. 1 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Society for Microbiology
21.01.2020
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.
In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection.
IMPORTANCE
It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. |
---|---|
AbstractList | ABSTRACT In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection.IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects.In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection.IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody response to natural infection are not well understood. Here, we assessed the immune response after H1N1 influenza virus infection in children and adults in a Nicaraguan household transmission study using an influenza virus protein microarray (IVPM). This technology allows us to simultaneously measure IgG and IgA antibody responses to hemagglutinins of many different virus strains and subtypes quantitatively with a high throughput. We found that children under 6 years of age responded to natural infection with a relatively narrow response that targeted mostly the hemagglutinin of the strain that caused the infection. Adults, however, have a much broader response, including a boost in antibodies to many group 1 subtype hemagglutinins. Also, a strong recall response against historic H1 hemagglutinins that share the K133 epitope with the pandemic H1N1 virus was observed. Of note, some children, while responding narrowly within H1 and group 1 hemagglutinins, induced a boost to H3 and other group 2 hemagglutinins when infected with H1N1 when they had experienced an H3N2 infection earlier in life. This is an interesting phenomenon providing evidence for immune imprinting and a significant new insight which might be leveraged in future universal influenza virus vaccine strategies. Finally, preexisting immunity to pandemic H1 hemagglutinins was significantly associated with protection from infection in both children and adults. In adults, preexisting immunity to non-H1 group 1 hemagglutinins was also significantly associated with protection from infection. IMPORTANCE It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a special immunological imprint which shapes immune responses to future infections with antigenically related influenza virus strains. Imprinting has been implicated in both protective effects as well as blunting of the immune response to vaccines. Despite the fact that this phenomenon was already described almost 60 years ago, we have very little detailed knowledge of the characteristics and breadth of the immune response to the first exposure(s) to influenza virus in life and how this compares to later exposure as adults. Here, we investigate these immune responses in detail using an influenza virus protein microarray. While our findings are mostly descriptive in nature and based on a small sample size, they provide a strong basis for future large-scale studies to better understand imprinting effects. |
Author | Meade, Philip Krammer, Florian Kirkpatrick, Ericka Amanat, Fatima Maier, Hannah E. Javier, Andres Strohmeier, Shirin Nachbagauer, Raffael Kuan, Guillermina Gordon, Aubree Gresh, Lionel Balmaseda, Angel Ito, Kimihito |
Author_xml | – sequence: 1 givenname: Philip surname: Meade fullname: Meade, Philip organization: Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA – sequence: 2 givenname: Guillermina surname: Kuan fullname: Kuan, Guillermina organization: Sustainable Sciences Institute, Managua, Nicaragua, Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua – sequence: 3 givenname: Shirin surname: Strohmeier fullname: Strohmeier, Shirin organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA – sequence: 4 givenname: Hannah E. surname: Maier fullname: Maier, Hannah E. organization: Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA – sequence: 5 givenname: Fatima surname: Amanat fullname: Amanat, Fatima organization: Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA – sequence: 6 givenname: Angel surname: Balmaseda fullname: Balmaseda, Angel organization: Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua, Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministry of Health, Managua, Nicaragua – sequence: 7 givenname: Kimihito surname: Ito fullname: Ito, Kimihito organization: Division of Bioinformatics, Hokkaido University Research Center for Zoonosis Control, Kitaku, Japan – sequence: 8 givenname: Ericka surname: Kirkpatrick fullname: Kirkpatrick, Ericka organization: Graduate School of Biomedical Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA – sequence: 9 givenname: Andres surname: Javier fullname: Javier, Andres organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA – sequence: 10 givenname: Lionel surname: Gresh fullname: Gresh, Lionel organization: Centro de Salud Sócrates Flores Vivas, Ministry of Health, Managua, Nicaragua – sequence: 11 givenname: Raffael orcidid: 0000-0001-5568-5420 surname: Nachbagauer fullname: Nachbagauer, Raffael organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA – sequence: 12 givenname: Aubree surname: Gordon fullname: Gordon, Aubree organization: Centers of Excellence for Influenza Research and Surveillance (CEIRS), Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan, USA, St. Jude Center of Excellence for Influenza Research and Surveillance, Memphis, Tennessee, USA – sequence: 13 givenname: Florian orcidid: 0000-0003-4121-776X surname: Krammer fullname: Krammer, Florian organization: Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA, Centers of Excellence for Influenza Research and Surveillance (CEIRS), Center for Research on Influenza Pathogenesis (CRIP), New York, New York, USA |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31964741$$D View this record in MEDLINE/PubMed |
BookMark | eNp1kstvEzEQxleoiJbSI1e0Ry5bPH7FviClEY9IFUgIuFpeP1pXjh3s3aLy1-M0pSJI-OKx_ZtvxvrmeXeUcnJd9xLQOQAWbzYXIZ8jgikZQD7pTjAwNCwYwNEu5jBgwPK4O6v1BrVFCAiCnnXHBCSnCwonXVonH2eXfun-eyhz7dvZmSnk1CI7G1d73X_SpeSf_TJNYcz2rv_i6jan6vqQ-tV1iLa41I_z1NCLkrVtgNExHnBLO8epvuieeh2rO3vYT7tv7999XX0cLj9_WK-Wl4NhIKfBA_dYUoqwA2xHQxlgg633I_hx5EAs9YJprEX7CYxUauCaOO0FAusJIqfdeq9rs75R2xI2utyprIO6v8jlSukyBROdEpJKxIRjnHCKMYjRSs4Q5gI5wTw0rbd7re08bpw1Lk1FxwPRw5cUrtVVvlVcLihbsCbw-kGg5B-zq5PahGpcjDq5PFeFCSWsmSN2fb_6u9ZjkT-GNWDYA6bkWovzjwggtZsJtZsJdT8TCmTjyT-8CZPe-dtaDfE_Wb8BtNS6JQ |
CitedBy_id | crossref_primary_10_1371_journal_ppat_1008583 crossref_primary_10_1038_s41467_024_47455_6 crossref_primary_10_1038_s41579_023_00945_8 crossref_primary_10_1038_s41586_020_2711_0 crossref_primary_10_1542_peds_2020_019901 crossref_primary_10_1093_infdis_jiae258 crossref_primary_10_1016_j_bioorg_2023_106712 crossref_primary_10_3390_vaccines11030593 crossref_primary_10_1038_s41467_021_23977_1 crossref_primary_10_1542_peds_2021_052173 crossref_primary_10_1016_j_chom_2024_06_015 crossref_primary_10_1128_mBio_02808_20 crossref_primary_10_1038_s41467_020_17488_8 crossref_primary_10_3390_v14112587 crossref_primary_10_7554_eLife_81457 crossref_primary_10_3389_fimmu_2020_610688 crossref_primary_10_3389_fimmu_2020_02057 crossref_primary_10_3390_vaccines11071241 crossref_primary_10_1128_jvi_00109_25 crossref_primary_10_1038_s41591_022_01690_w crossref_primary_10_1007_s11071_022_07661_7 crossref_primary_10_1038_s41590_021_01089_8 crossref_primary_10_1186_s12879_021_06988_7 crossref_primary_10_1080_09712119_2022_2133902 crossref_primary_10_3390_v13061109 crossref_primary_10_3389_fimmu_2022_987984 crossref_primary_10_1093_infdis_jiad029 crossref_primary_10_1016_j_vaccine_2021_05_064 crossref_primary_10_3390_v16050801 crossref_primary_10_1007_s44307_025_00057_9 crossref_primary_10_1128_jvi_01070_22 crossref_primary_10_3390_v13020278 crossref_primary_10_1038_s41467_020_16545_6 crossref_primary_10_3390_microbiolres12030044 crossref_primary_10_3390_vaccines9090979 crossref_primary_10_1038_s41467_024_47590_0 crossref_primary_10_3390_v13060965 crossref_primary_10_1038_s41541_022_00490_0 crossref_primary_10_1038_s41590_021_01122_w crossref_primary_10_3389_fimmu_2020_607333 crossref_primary_10_1038_s41590_021_01123_9 crossref_primary_10_3390_v13040619 crossref_primary_10_1038_s41590_021_01085_y crossref_primary_10_3390_v13071400 crossref_primary_10_1093_infdis_jiae122 crossref_primary_10_1172_JCI150613 crossref_primary_10_1126_science_abd4570 crossref_primary_10_3390_bios15030198 crossref_primary_10_1093_cid_ciac734 |
Cites_doi | 10.1084/jem.20130212 10.1038/emi.2017.98 10.1016/j.cell.2018.03.030 10.1016/j.chom.2019.01.002 10.1038/nature06890 10.1016/j.coviro.2016.12.004 10.1016/j.coviro.2014.07.007 10.1038/ncomms8708 10.1371/journal.pone.0043603 10.1006/viro.2000.0453 10.1128/JVI.03099-14 10.1126/science.1205669 10.1007/s11684-017-0602-z 10.1038/nm.4224 10.3791/51112 10.1016/j.chom.2016.05.014 10.1128/JVI.00169-19 10.1073/pnas.1409171111 10.1038/s41591-019-0463-x 10.1084/jem.20101352 10.1126/science.1256427 10.1126/science.1222908 10.3201/eid2410.161258 10.1056/NEJMoa0903810 10.1038/ni.3680 10.1016/j.coi.2018.05.010 10.3390/vaccines6020028 10.1038/ni.3684 10.1016/j.vaccine.2017.08.044 10.1371/journal.ppat.1002802 10.1038/s41577-019-0143-6 10.1126/science.aag1322 10.1016/j.vaccine.2018.04.063 10.1128/mBio.01996-15 10.1126/sciimmunol.aan2676 10.1126/scitranslmed.3006637 |
ContentType | Journal Article |
Copyright | Copyright © 2020 Meade et al. Copyright © 2020 Meade et al. 2020 Meade et al. |
Copyright_xml | – notice: Copyright © 2020 Meade et al. – notice: Copyright © 2020 Meade et al. 2020 Meade et al. |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 5PM DOA |
DOI | 10.1128/mBio.03243-19 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE CrossRef |
Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Biology |
DocumentTitleAlternate | Influenza Virus Antibodies in Infected Patients |
EISSN | 2150-7511 |
ExternalDocumentID | oai_doaj_org_article_8949058e563642218bd96502680e85f1 PMC6974575 31964741 10_1128_mBio_03243_19 |
Genre | Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NIAID NIH HHS grantid: HHSN272201400008C – fundername: NIAID NIH HHS grantid: P01 AI097092 – fundername: NIAID NIH HHS grantid: R01 AI120997 – fundername: NIAID NIH HHS grantid: T32 AI007647 – fundername: NIAID NIH HHS grantid: HHSN272201400006C – fundername: ; grantid: HHSN272201400008C – fundername: ; grantid: HHSN272201400006C – fundername: ; grantid: AI120997 |
GroupedDBID | --- 0R~ 53G 5VS AAFWJ AAGFI AAUOK AAYXX ADBBV AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV BTFSW CITATION DIK E3Z EBS FRP GROUPED_DOAJ GX1 H13 HYE HZ~ KQ8 M48 O5R O5S O9- OK1 P2P PGMZT RHI RNS RPM RSF CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c519t-f16f294402e12dbc4512c2dffb1fbb613d4f85a2a83191b49a16a3eaf801df303 |
IEDL.DBID | M48 |
ISSN | 2161-2129 2150-7511 |
IngestDate | Wed Aug 27 01:32:09 EDT 2025 Thu Aug 21 13:41:37 EDT 2025 Fri Jul 11 08:26:46 EDT 2025 Mon Jul 21 05:38:58 EDT 2025 Thu Apr 24 23:05:39 EDT 2025 Tue Jul 01 01:52:42 EDT 2025 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | influenza influenza virus cross-reactivity natural infection imprinting heterosubtypic immunity |
Language | English |
License | Copyright © 2020 Meade et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c519t-f16f294402e12dbc4512c2dffb1fbb613d4f85a2a83191b49a16a3eaf801df303 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0003-4121-776X 0000-0001-5568-5420 |
OpenAccessLink | https://doaj.org/article/8949058e563642218bd96502680e85f1 |
PMID | 31964741 |
PQID | 2343503380 |
PQPubID | 23479 |
ParticipantIDs | doaj_primary_oai_doaj_org_article_8949058e563642218bd96502680e85f1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_6974575 proquest_miscellaneous_2343503380 pubmed_primary_31964741 crossref_primary_10_1128_mBio_03243_19 crossref_citationtrail_10_1128_mBio_03243_19 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 20200121 |
PublicationDateYYYYMMDD | 2020-01-21 |
PublicationDate_xml | – month: 1 year: 2020 text: 20200121 day: 21 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: 1752 N St., N.W., Washington, DC |
PublicationTitle | mBio |
PublicationTitleAlternate | mBio |
PublicationYear | 2020 |
Publisher | American Society for Microbiology |
Publisher_xml | – name: American Society for Microbiology |
References | e_1_3_2_26_2 e_1_3_2_27_2 e_1_3_2_28_2 e_1_3_2_29_2 e_1_3_2_20_2 e_1_3_2_21_2 e_1_3_2_22_2 e_1_3_2_23_2 e_1_3_2_24_2 e_1_3_2_25_2 e_1_3_2_9_2 e_1_3_2_15_2 e_1_3_2_38_2 e_1_3_2_8_2 e_1_3_2_16_2 e_1_3_2_37_2 e_1_3_2_7_2 e_1_3_2_17_2 e_1_3_2_6_2 e_1_3_2_18_2 e_1_3_2_19_2 e_1_3_2_30_2 e_1_3_2_32_2 e_1_3_2_10_2 e_1_3_2_31_2 e_1_3_2_5_2 e_1_3_2_11_2 e_1_3_2_34_2 e_1_3_2_12_2 e_1_3_2_33_2 e_1_3_2_3_2 Francis T (e_1_3_2_4_2) 1960; 104 e_1_3_2_13_2 e_1_3_2_36_2 e_1_3_2_2_2 e_1_3_2_14_2 e_1_3_2_35_2 |
References_xml | – ident: e_1_3_2_11_2 doi: 10.1084/jem.20130212 – ident: e_1_3_2_14_2 doi: 10.1038/emi.2017.98 – ident: e_1_3_2_18_2 doi: 10.1016/j.cell.2018.03.030 – ident: e_1_3_2_26_2 doi: 10.1016/j.chom.2019.01.002 – ident: e_1_3_2_17_2 doi: 10.1038/nature06890 – ident: e_1_3_2_10_2 doi: 10.1016/j.coviro.2016.12.004 – ident: e_1_3_2_9_2 doi: 10.1016/j.coviro.2014.07.007 – ident: e_1_3_2_31_2 doi: 10.1038/ncomms8708 – ident: e_1_3_2_37_2 doi: 10.1371/journal.pone.0043603 – ident: e_1_3_2_24_2 doi: 10.1006/viro.2000.0453 – ident: e_1_3_2_19_2 doi: 10.1128/JVI.03099-14 – ident: e_1_3_2_30_2 doi: 10.1126/science.1205669 – ident: e_1_3_2_33_2 doi: 10.1007/s11684-017-0602-z – ident: e_1_3_2_35_2 doi: 10.1038/nm.4224 – ident: e_1_3_2_36_2 doi: 10.3791/51112 – ident: e_1_3_2_34_2 doi: 10.1016/j.chom.2016.05.014 – ident: e_1_3_2_8_2 doi: 10.1128/JVI.00169-19 – ident: e_1_3_2_12_2 doi: 10.1073/pnas.1409171111 – ident: e_1_3_2_3_2 doi: 10.1038/s41591-019-0463-x – ident: e_1_3_2_38_2 doi: 10.1084/jem.20101352 – ident: e_1_3_2_27_2 doi: 10.1126/science.1256427 – ident: e_1_3_2_29_2 doi: 10.1126/science.1222908 – volume: 104 start-page: 572 year: 1960 ident: e_1_3_2_4_2 article-title: On the doctrine of original antigenic sin publication-title: Proc Am Philos Soc – ident: e_1_3_2_15_2 doi: 10.3201/eid2410.161258 – ident: e_1_3_2_16_2 doi: 10.1056/NEJMoa0903810 – ident: e_1_3_2_21_2 doi: 10.1038/ni.3680 – ident: e_1_3_2_5_2 doi: 10.1016/j.coi.2018.05.010 – ident: e_1_3_2_6_2 doi: 10.3390/vaccines6020028 – ident: e_1_3_2_13_2 doi: 10.1038/ni.3684 – ident: e_1_3_2_25_2 doi: 10.1016/j.vaccine.2017.08.044 – ident: e_1_3_2_28_2 doi: 10.1371/journal.ppat.1002802 – ident: e_1_3_2_2_2 doi: 10.1038/s41577-019-0143-6 – ident: e_1_3_2_7_2 doi: 10.1126/science.aag1322 – ident: e_1_3_2_20_2 doi: 10.1016/j.vaccine.2018.04.063 – ident: e_1_3_2_22_2 doi: 10.1128/mBio.01996-15 – ident: e_1_3_2_32_2 doi: 10.1126/sciimmunol.aan2676 – ident: e_1_3_2_23_2 doi: 10.1126/scitranslmed.3006637 |
SSID | ssj0000331830 |
Score | 2.4525728 |
Snippet | It is known since Thomas Francis, Jr. published his first paper on original antigenic sin in 1960 that the first infection(s) with influenza virus leaves a... In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the antibody... ABSTRACT In contrast to influenza virus vaccination, natural infection induces long-lived and relatively broad immune responses. However, many aspects of the... |
SourceID | doaj pubmedcentral proquest pubmed crossref |
SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
SubjectTerms | Adult Age Factors Animals Antibodies, Viral - immunology Antigens, Viral - immunology Child Clinical Science and Epidemiology Cross Reactions cross-reactivity Editor's Pick heterosubtypic immunity Humans Immunoglobulin A - immunology Immunoglobulin G - immunology Immunologic Memory imprinting influenza Influenza Vaccines - immunology influenza virus Influenza, Human - epidemiology Influenza, Human - immunology Influenza, Human - virology Mice natural infection Orthomyxoviridae - classification Orthomyxoviridae - immunology Phylogeny Vaccination |
SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1NS8QwEA0iCF7Eb9cvIogno03aZtPjKooKehAVbyFpEixoVna7B_31TtLusiuKF6_t0KaZSd4bMn2D0KHguS65oSTV1pLMqYJol6ZEaGqNUkrQKNd0e8evHrOb5_x5qtVXqAlr5IGbiTsVRVYkubA5T4EqAyBpUwCrYFwkVuQuJj6AeVPJVNyD0xCryVhUk4nTt7Oqf5IAfUhJUNWZAqGo1f8TwfxeJzkFPJfLaKlljLjXjHQFzVm_ihaaHpIfa8hfN21GPhV-qgajIb5uy6s8Dm05YBvACt9FqUXc83Wl--YD3zeVsRZXHp-3v3NjParBFPJyZcAAfPc6Y9cLSh3DdfR4efFwfkXaJgqkBHJWE0e5Y0UGaaKlzOgyA4QvmXFOU6c1gLnJnMgVUwIWI9VZoShXqVUOoMs4ALgNNO_73m4hzLvGFLrs2iiEZoVmgsLzyoxrnrgy6aDj8azKslUYD40uXmXMNJiQwQkyOkHSooOOJubvjbTGb4ZnwUUTo6CIHS9AnMg2TuRfcdJBB2MHS1hB4VhEedsfDSVLgTJCwAj4gM3G4ZNXRb0yIF0d1J0JhZmxzN7x1UtU6eaQqQEX3v6Pwe-gRRby_IQSRnfRfD0Y2T0gQ7Xej3H_BfIIBk4 priority: 102 providerName: Directory of Open Access Journals |
Title | Influenza Virus Infection Induces a Narrow Antibody Response in Children but a Broad Recall Response in Adults |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31964741 https://www.proquest.com/docview/2343503380 https://pubmed.ncbi.nlm.nih.gov/PMC6974575 https://doaj.org/article/8949058e563642218bd96502680e85f1 |
Volume | 11 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELbQEBIvaPwujMlIiCc8Yidx7QeEuomxIW0PiKK-WXZsQ6TijDaV1v31OztpIdOQeMlDcnJi353vO8f-DqE3gpem4paS3DhHCq8lMT7PiTDUWa21oImu6eycn0yLL7Ny9odSqB_A5a2pXawnNV3MDy5_rz-Cw3_oDsCI978O6-YgA2SQk0gAeheC0jj66FmP9NOknEfjjSsuDDAOgQlbbhg3b7YwiFCJyP829HlzE-VfUel4Fz3o4SSedPp_iO648Ajd6wpMrh-jcNrVILnS-Hu9WC3xab_3KuBYswPmCKzxeeJhxJPQ1qaxa_y12zbrcB3wUX_WG5tVC6KQtGsLAqDY-UBuEmk8lk_Q9PjTt6MT0ldYIBUgt5Z4yj2TBeSQjjJrqgLCf8Ws94Z6YyDS28KLUjMtwFOpKaSmXOdOe4hr1kP0e4p2QhPcc4T52FppqrFLLGlOGCYotFcV3PDMV9kIvduMqqp6-vFYBWOuUhrChIpKUEkJisoRersVv-h4N_4leBhVtBWKdNnpRrP4oXrvU0IWMiuFK3kO-RagGmMlQFPGReZE6ekIvd4oWIF7xX8mOrhmtVQsBzwJxiOgA886hW9flcjMAJGN0HhgCoNvGT4J9c9E4c0hjQOg_OJ_e_kS3Wcx0c-i6e6hnXaxcq8ADbVmP60iwPXzjO4nm78GFoYJlg |
linkProvider | Scholars Portal |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Influenza+Virus+Infection+Induces+a+Narrow+Antibody+Response+in+Children+but+a+Broad+Recall+Response+in+Adults&rft.jtitle=mBio&rft.au=Meade%2C+Philip&rft.au=Kuan%2C+Guillermina&rft.au=Strohmeier%2C+Shirin&rft.au=Maier%2C+Hannah+E.&rft.date=2020-01-21&rft.issn=2161-2129&rft.eissn=2150-7511&rft.volume=11&rft.issue=1&rft_id=info:doi/10.1128%2FmBio.03243-19&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_mBio_03243_19 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=2161-2129&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=2161-2129&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=2161-2129&client=summon |